Grants and contracts awarded to Yale School of Medicine

January/February 2006

  • Meenakshi Alreja, NIH, Cholinergic and GABAergic Mechanisms in the Septohippocampal Pathway, 5 years, $1,545,940
  • Peter Cresswell, NIH, Role of Endocytosis in Cell Recognition, 5 years, $2,043,750
  • Sankar Ghosh, NIH, Mechanism of T Cell-Receptor Mediated Activation of NFκB, 5 years, $2,043,750
  • Tibor Hajszan, NIH, Antidepressant Effect on Hippocampal Synaptogenesis, 3 years, $850,966
  • Nathan Hansen, NIH, Intervention for HIV+ Adults With Childhood Sexual Abuse, 4 years, $899,966
  • Ralph Hoffman, NIH, rTMS Clinical Trial for Auditory Hallucinations, 5 years, $2,135,810
  • Akiko Iwasaki, NIH, Viral Recognition by Plasmacytoid Dendritic Cell, 4 years, $2,043,750
  • Jeffrey Kahn, NIH, The Role of a Novel Coronavirus in Kawasaki Disease, 2 years, $437,795
  • Robert LaMotte, NIH, Satellite Glia and Sensory Coding: Implications for Pain, 1 year, $404,663
  • Peter Novick, NIH, Structure and Inheritance of the Endoplasmic Reticulum, 3 years, $1,209,900
  • Jordan Pober, NIH, Alloimmunity to Progenitor Cell-Derived Human Vascular Cells, 4 years, $2,993,312
  • Pasko Rakic, NIH, Apoptosis and Renewal of Neural Progenitor Cells, 5 years, $1,636,221
  • David Rimm, NIH, Predicting Metastasis in Melanoma, 3 years, $1,044,764
  • Scott Rivkees, NIH, Anti-Adenosine Therapy of Neonatal Brain Injury, 1 year, $183,938
  • Craig Roy, NIH, Evasion of Antigen Presentation by Vacuolar Pathogens, 5 years, $2,043,750; NIH, Modulation of Host Cell Functions by Coxiella burnetii, 4 years, $1,839,375
  • Kerry Russell, NIH, Cardiovascular Effects of Endothelial-Derived Neuregulin, 4 years, $2,037,464
  • Mark Shlomchik, NIH, Differential GVHD Induction by Naive and Memory T Cells, 4 years, $1,635,000
  • Mark Solomon, NIH, Anaphase Promoting Complex-Mediated Proteolysis, 3 years, $1,406,100
  • Stephen Strittmatter, NIH, Nogo Receptor Antagonist for Ischemic Stroke Recovery, 5 years, $1,430,625
  • Scott Strobel, NIH, Mechanism of Ribosome-Catalyzed Peptide Bond Formation, 3 years, $1,322,074
  • Joann Sweasy, NIH, DNA PolymeraseΒ and Colon Cancer, 2 years, $341,715

  • Serap Aksoy, Ambrose Monell Foundation, New Strategies for African Trypanosomiasis Control, 1 year, $100,000
  • Jeffrey Bender, Pfizer, Inc., Atorvastatin’s Impact on Vascular Wall Inflammation by Interfering with Isoprehylation and RAC-1 Function, 16 months, $64,690
  • Elizabeth Bradley, William J. Clinton Foundation, Ethiopia Hospital Management Initiative, 1 year, $604,610
  • Margaret Briggs-Gowan, University of Illinois, Chicago, Observational Measurement of Preschool Behavior Problems, 7 months, $18,842
  • Susan Busch, Robert Wood Johnson Foundation, The Effect of State Parity Laws on Children, 1 year, $64,872
  • Jan Czyzyk, American Cancer Society, Inc., Alternative Effectors of Ras GTPase in T Cell Activation, 4 years, $720,000
  • Maria Diuk-Wasser, G. Harold and Leila Y. Mathers Charitable Foundation, Development of an Interactive Internet Site for Lyme Disease Education, 1 year, $51,425
  • Barbara Ehrlich, PKD Foundation for Research in Polycystic Kidney Disease, Molecular Coupling Between the InsP3 Receptor and Polycystin 2: InsP3 Receptor Isoform Specificity for Cyst Formation, 1 year, $65,000
  • Gerald Friedland, Doris Duke Charitable Foundation, Supplement Provision of HIV Care, Antiretroviral Therapy and Prevention Through a Community-Based Program in Rural South Africa, 1 year, $25,000
  • Alan Garen, Breast Cancer Alliance, Inc., Breast Cancer Immunotherapy Using Targeted Nanoparticles Encoding an Icon, 1 year, $100,000
  • Walter Gilliam, Community Foundation for Greater New Haven, Mother Read/Father Read Evaluation, 1 year, $87,000
  • Nora Groce, International Labor Organization, The Impact of HIV/AIDS on Disabled Populations: Policy Interventions, 5 months, $30,000
  • Handan Gunduz-Bruce, National Alliance for Research on Schizophrenia and Depression, GABA-Glutamate Interactions and Psychosis, 2 years, $60,000
  • Melinda Irwin, Fred Hutchinson Cancer Research Center, TREC Coordination Center, 1 year, $22,346
  • Kathleen Koenig, Organization for Autism Research, Development of an Instrument for Measuring Change in Social Behavior in Children with Autism Spectrum Conditions: The Social Behavior Observation Measure, 2 years, $29,784
  • James Leckman, New York Medical College, Role of Group A Streptococcal Infection and HLA Type in TS and OCD, 1 year, $8,548
  • Guoyong Li, American Heart Association, Characterization of a Novel Monoamine Oxidase, Renalase, 3 years, $260,000
  • Xingguang Luo, Alcoholic Beverage Medical Research Foundation, Fine-Mapping Risk Alleles for Alcohol Dependence at the CHRM2 Locus, 1 year, $50,000
  • Linda Mayes, Patrick & Catherine Weldon Donaghue Medical Research Foundation, Minding the Baby: Home Visiting for Young Parents, 3 years, $79,636
  • Guillermo Mor, Laboratory Corporation of America Holdings, Ovarian Cancer Support, 3 years, $150,000; Novogen Limited, Assay of Induction of Apoptosis by Phenoxodiol in Cancer Cells, 1 year, $89,920
  • Utpal Pal, American Heart Association, Molecular Pathogenesis of Lyme Carditis, 6 months, $260,000
  • A. David Paltiel, Massachusetts General Hospital, Optimizing HIV Care in Less-Developed Countries, 3 years, $14,668
  • Reuven Rabinovici, Cellphire, Inc, The Efficacy of Freeze-Dried Platelets in a Rat Model of Uncontrolled Hemorrhagic Shock, 1 year, $125,000
  • Robert Roth, Organon Laboratories Ltd., Influence of Asenapine on Dopamine and Serotonin Turnover in the Phencyclidine Model of Frontal Cortical Dysfunction in Non-Human Primates, 2 years, $68,670
  • David Rothstein, University of California–San Diego, Endotoxin and Allergy: Modulation by CTLA4, 17 months, $8,226
  • Joseph Schlessinger, Ludwig Institute for Cancer Research, Coupling Between FGF and Signaling via TGF Receptors, 1 year, $75,000
  • Robert Schultz, Vanderbilt University, Perpetual Expertise Network: Dynamics of Object Perception, 1 year, $46,325
  • Hong Wang, Harvard University, Social Experimental Study on RMHC Community-Based Health Insurance in Rural China, 3 years, $86,237
  • Carol Weitzman, The Children’s Fund of Connecticut, Behavioral Health of Young Children in Primary Care Settings, 2 years, $178,561
  • Dagan Wells, ART Institute of New York and New Jersey, Analysis of Cell-Cycle Checkpoints in Human Oocytes, 15 months, $16,792
  • Herbert Yu, American Association for Cancer Research, Methylator Phenotype of Insulin-Like Growth Factors in Breast Cancer, 2 years, $160,000

Download this issue as a PDFDownload PDF version

Medicine@Yale, the bimonthly newsletter of Yale School of Medicine (YSM), chronicles achievements
of YSM in basic and clinical research, medical education, and health care. Read More...